España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Aprea Therapeutics
APRE
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Aprea Therapeutics (APRE) Forecast
News
Earnings
Aprea Therapeutics (APRE) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Aprea Therapeutics (NASDAQ:APRE) Stock
Aprea Therapeutics Stock (NASDAQ: APRE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Wednesday, December 11, 2024
Aprea Therapeutics Announces Twice Daily Dosi...
Benzinga Newsdesk
Monday, November 18, 2024
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Thursday, November 07, 2024
Aprea Therapeutics Q3 EPS $(0.64) Beats $(0.7...
Benzinga Newsdesk
Thursday, October 24, 2024
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Wednesday, October 23, 2024
Aprea Therapeutics Presents Preliminary Findi...
Benzinga Newsdesk
Tuesday, October 15, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Tuesday, August 13, 2024
Wedbush Reiterates Outperform on Aprea Therap...
Benzinga Newsdesk
Monday, August 12, 2024
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Aprea Therapeutics Q2 EPS $(0.58) Beats $(0.6...
Benzinga Newsdesk
Monday, June 24, 2024
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Friday, June 21, 2024
Aprea Therapeutics To Host Virtual KOL Event ...
Benzinga Newsdesk
Aprea Therapeutics To Host Virtual KOL Event ...
Benzinga Newsdesk
Monday, June 17, 2024
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Aprea Therapeutics Doses First Patient In Pha...
Benzinga Newsdesk
Tuesday, May 28, 2024
Aprea Therapeutics Safety Review Committee En...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Aprea Therapeutics Q1 EPS $(0.67) Beats $(0.7...
Benzinga Newsdesk
Wednesday, April 10, 2024
Aprea Therapeutics Announces Presentations On...
Benzinga Newsdesk
Thursday, April 04, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, March 27, 2024
Wedbush Maintains Outperform on Aprea Therape...
Benzinga Newsdesk
Tuesday, March 26, 2024
HC Wainwright & Co. Maintains Buy on Aprea Th...
Benzinga Newsdesk
Aprea Therapeutics: Q4 Earnings Insights
Benzinga Insights
Monday, March 11, 2024
Why Is Precision Oncology-Focused Aprea Therapeutics Stock Trading Higher On Monday?
Vandana Singh
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Market-Moving News for March 11th
Benzinga Newsdesk
Aprea Therapeutics shares are trading higher ...
Benzinga Newsdesk
Aprea Therapeutics Announces Private Placemen...
Benzinga Newsdesk
Aprea Therapeutics Announces FDA Clearance Of...
Benzinga Newsdesk
Tuesday, February 06, 2024
Aprea Therapeutics Announces Submission Of IN...
Benzinga Newsdesk
Friday, January 26, 2024
Aprea Therapeutics Entered Into An At-market Offering Agreement With H.C. Wainwright Under Which They May Offer And Sell Up To $1M Of Common Stock From Time To Time
Charles Gross
Thursday, January 04, 2024
Aprea Therapeutics Provided A Corporate Updat...
Benzinga Newsdesk
Thursday, November 09, 2023
Aprea Therapeutics Q3 EPS $(0.86) Beats $(1.1...
Benzinga Newsdesk
Wednesday, November 01, 2023
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Monday, October 30, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Monday, October 16, 2023
Aprea Unveils Initial Clinical Data On ATRi, ...
Benzinga Newsdesk
Monday, September 25, 2023
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
Wednesday, September 13, 2023
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Monday, September 11, 2023
Aprea Therapeutics Says Updated Preclinical D...
Benzinga Newsdesk
Monday, September 04, 2023
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
Friday, August 25, 2023
Director at Aprea Therapeutics Acquires Company Stock Options Worth 12,500 Shares
Benzinga Insights
Thursday, August 24, 2023
Aprea Therapeutics Names Richard Peters As Ch...
Benzinga Newsdesk
Thursday, August 10, 2023
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Tuesday, July 18, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Friday, June 09, 2023
Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
Lisa Levin
Wednesday, May 24, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, May 16, 2023
HC Wainwright & Co. Reiterates Buy on Aprea T...
Benzinga Newsdesk
Aprea Therapeutics Q1 EPS $(1.34) Up From $(7.20) YoY
Happy Mohamed
Friday, April 07, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, April 03, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch